Psychopharmacology of ADHD in pediatrics: current advances and issues

نویسندگان

  • Donald E Greydanus
  • Ahsan Nazeer
  • Dilip R Patel
چکیده

Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral developmental disorder found in 3% to 8% of children and adolescents. An important part of ADHD management is psychopharmacology, which includes stimulants, norepinephrine reuptake inhibitors, alpha-2 agonists, and antidepressants. Medications with the best evidence-based support for ADHD management are the stimulants methylphenidate and amphetamine. A number of newer, long-acting stimulants are now available and a number of new medications are considered that are under current research.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Current issues in child and adolescent psychopharmacology. Part 2: Anxiety and obsessive–compulsive disorders, autism, Tourette’s and schizophrenia

Part 1 of this two-part consideration of child and adolescent psychopharmacology focused on attention–deficit hyperactivity disorder (ADHD), depression and bipolar disorder (Coghill, 2003). This second paper concentrates on current pharmacological approaches to the treatment of anxiety disorders, obsessive–compulsive disorders, autism, Tourette syndrome and schizophrenia. The aim is to describe...

متن کامل

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

BACKGROUND AND OBJECTIVE Hyperactivity, impulsivity, and inattention (referred to as "ADHD [attention-deficit/hyperactivity disorder] symptoms") occur in 41% to 78% of children with autism spectrum disorders (ASDs). These symptoms often affect quality of life, interfering with learning or interventions that target primary ASD symptoms. This practice pathway describes the guidelines for evaluati...

متن کامل

Psychopharmacology for Attention-Defi cit/Hyperactivity Disorder in Japan

In Japan, treatment with medication for attention-defi cit/hyperactivity disorder (ADHD) is less favorable than psychosocial treatment, as in Europe. Overall, Japanese guidelines offer few descriptions of stimulant-refractory or complicated ADHD treatments. However, carbamazepine has been preferably prescribed for ADHD with electroencephalogram abnormality or aggression. Only one stimulant (lon...

متن کامل

Treatment of adult ADHD: a clinical perspective.

Adult attention deficit/hyperactivity disorder (ADHD) has moved from the blurred edge of clinical focus to clear recognition as a prevalent and significant disorder in its own right. It is a relatively common comorbidity which if identified and treated may open the door to better outcomes for hard-to-treat patients. Conversely, failure to identify and treat adult ADHD is linked to negative outc...

متن کامل

ADHD matures: time for practitioners to do the same?

Attention deficit and hyperactivity disorder (ADHD) is not restricted to children. Abundant evidence from follow-up studies accumulated since the 1970s supports the concept of ADHD in adulthood. Genetic research points to a heritability of 76%, and neuroimaging studies have reported structural and functional brain abnormalities in patients with ADHD. Contrary to popular belief, ADHD is not a cu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 5  شماره 

صفحات  -

تاریخ انتشار 2009